本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nasus Pharma Ltd.

2.49
-0.0100-0.40%
盤後2.35-0.1400-5.62%19:44 EDT
成交量:8.54萬
成交額:21.14萬
市值:2,927.97萬
市盈率:-9.46
高:2.54
開:2.46
低:2.35
收:2.50
52周最高:9.99
52周最低:2.29
股本:1,175.89萬
流通股本:621.40萬
量比:0.48
換手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-0.2633
每股收益(LYR):-0.2180
淨資產收益率:--
總資產收益率:-106.39%
市淨率:-6.79
市盈率(LYR):-11.42

資料載入中...

公司資料

公司名字:
Nasus Pharma Ltd.
交易所:
AMEX
成立時間:
2019
員工人數:
2
公司地址:
Yigal Alon 65,Tel Aviv-Yafo,Israel
郵編:
6744317
傳真:
- -
簡介:
Nasus Pharma Ltd.是一家以色列公司,於2019年5月在以色列註冊成立。他們是一家臨床階段的專業製藥公司,主要專註於開發治療緊急醫療狀況的鼻內藥物。他們正在開發一種獨特的PBI技術,擁有專門的產品組合,以應對急性醫療狀況和公共健康威脅。

董事

名稱
職位
Dan Teleman
Chief Executive Officer, Director
Udi Gilboa
Co-Founder and Executive Chairman of the Board
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
David Silberman
Director
Isaac Israel
Director
Ronnie Hershman
Director
Sharon Shacham
Director

股東

名稱
職位
Dan Teleman
Chief Executive Officer, Director
Eyal Rubin
Executive Vice President and Chief Financial Officer
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Galia Temtsin Kryaz
Director of CMC and Product Development
Oren Elmaliach
Director of Finance
Tair Lapidot
Vice President of Research and Development and Clinical Development
Udi Gilboa
Co-Founder and Executive Chairman of the Board